Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBiome Tech Regulatory News (BIOM)

  • There is currently no data for BIOM

Trading Update

25 Apr 2016 07:00

RNS Number : 1437W
Biome Technologies PLC
25 April 2016
 

25 April 2016

 

 

Biome Technologies plc

("Biome", the "Company" or the "Group")

 

Trading Update

 

 

In advance of its Annual General Meeting today, Biome, a leading bioplastics and radio frequency technology business, is pleased to announce a trading update for the three months ended 31 March 2016.

 

Total Group revenues achieved for the first three months of the year were £1.1m, in line with the same quarter last year (2015: £1.1m).

 

The Group made a small profit before interest, tax, depreciation, amortisation, and share option charges in this quarter (based on unaudited management accounts).

 

The Group's cash position as at 31 March 2016 was £1.6m (31 December 2015: £1.6m) reflecting the current trading activity. Increases in capitalised development spend were offset by working capital reductions.

 

Bioplastics Division

Revenues in the Bioplastics division in Q1 2016 were £0.2m (Q1 2015: £0.5m) reflecting the timings of campaign production runs in the US single-serve coffee market. The new temperature-tolerant material underwent final customer production run trials in the quarter and revenues of this product are expected to build over the coming months.

 

Further progress has been made on the development of a biodegradable non-woven mesh. The Group also received further government funding of £0.7m in the quarter, highlighted in the 2015 full year results, to continue its medium term development work on bio-based materials.

 

Stanelco RF Technologies Division

Revenues for Q1 2016 in the RF Technologies division were £0.9m (Q1 2015: £0.6m). Good revenue levels were supported by orders for fibre optic furnaces and activity associated with the £1.5m contract to supply advanced analytical equipment to a customer in a regulated industry. Both systems for this contract are due to be delivered before the end of June 2016.

 

Outlook

Biome continues to make good progress against the strategy as set out in the Group's full year results in March 2016 and against this background the Board remains confident in the Group's outlook for the remainder of the year.

 

 

 

 

- Ends -

 

 

 

 

For further information please contact:

 

Biome Technologies plc

 

Paul Mines, Chief Executive Officer

 

Declan Brown, Group Finance Director

 

www.biometechnologiesplc.com

Tel: +44 (0) 2380 867 100

 

Allenby Capital

 

David Hart/Alex Brearley (Nominated Adviser)

Chris Crawford/Kelly Gardiner (Broker)

 

www.allenbycapital.com

Tel: +44 (0) 20 3328 5656

 

 

 

FTI Consulting

 

Oliver Winters

www.fticonsulting.com

Tel: +44 (0) 20 3727 1535

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTAKQDQKBKBPQB
Date   Source Headline
21st Mar 20257:00 amRNSCancellation- Biome Technologies PLC
13th Mar 202512:22 pmRNSResult of GM & update on Cancellation
21st Feb 20257:00 amRNSProposed Cancellation & Notice of GM
18th Dec 20247:00 amRNSSecured Funding Facility
4th Dec 20247:00 amRNSTrading Update and Board Change
13th Nov 20247:00 amRNSTrading Update
25th Oct 20247:00 amRNSAppointment of Non-Executive Director
30th Sep 20245:00 pmRNSTotal Voting Rights
30th Sep 202411:08 amRNSContract win for Stanelco RF Division
20th Sep 20247:00 amRNSInterim Results
13th Sep 202410:58 amRNSHolding(s) in Company
12th Sep 202411:43 amRNSHolding(s) in Company
11th Sep 20243:01 pmRNSHolding(s) in Company
10th Sep 20247:00 amRNSHolding(s) in Company
9th Sep 20244:51 pmRNSHolding(s) in Company
4th Sep 20242:39 pmRNSResult of General Meeting and TVR
30th Aug 20245:00 pmRNSTotal Voting Rights
23rd Aug 20242:42 pmRNSHolding(s) in Company
22nd Aug 202411:00 amRNSHolding(s) in Company
22nd Aug 20247:00 amRNSResult of Retail Offer, Director dealing and TVR
21st Aug 20244:12 pmRNSHolding(s) in Company
21st Aug 20241:41 pmRNSHolding(s) in Company
16th Aug 20247:05 amRNSRetail offer to raise up to £80,000
16th Aug 20247:01 amRNSProposed Fundraise and other matters
16th Aug 20247:00 amRNSTrading update
10th Jul 20247:00 amRNSDirectorate Change
8th Jul 20247:00 amRNSTrading update
12th Jun 20247:00 amRNSGrant of Options
29th May 202410:57 amRNSResult of AGM, Interim CFO and Directorate Change
22nd May 20242:27 pmRNSContract win for Stanelco RF Division
15th May 20247:00 amRNSNotice of AGM and 2023 Annual Report
29th Apr 20247:01 amRNSTrading Update
29th Apr 20247:00 amRNSFinal Results 2023
15th Mar 20247:00 amRNSContract win for Stanelco RF Division
11th Mar 20241:59 pmRNSIssue of Convertible Loan Notes, PDMR Notification
15th Feb 20242:54 pmRNSContract win for RF Division
6th Feb 20247:00 amRNSTrading Update
13th Nov 20237:00 amRNSTrading Update
10th Oct 20234:32 pmRNSGrant of Options
27th Sep 20237:00 amRNSInterim Results
26th Jul 20237:00 amRNSTrading Update
30th Jun 20235:00 pmRNSTotal Voting Rights
22nd Jun 20237:00 amRNSContract win for Stanelco RF Division
31st May 20237:00 amRNSIssue of Equity, Director/PDMR Shareholding & TVR
25th May 20232:57 pmRNSAppointment of Non-Executive Director
25th May 202312:45 pmRNSResult of AGM
2nd May 20231:05 pmRNSDirector/PDMR Shareholding
27th Apr 20237:00 amRNSNotice of AGM and 2022 Annual Report
26th Apr 20237:01 amRNSTrading Update
26th Apr 20237:00 amRNSFinal Results 2022

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.